There is immense untapped potential in the use of Real World Evidence (RWE) in medical product development. RWE can decrease costs while generating outcomes that matter to patients, but effective outcomes rely on proper curation and validation of data, and proper linking of datasets – as well as a knowledge of regulatory thinking on the use of RWE across the healthcare value chain.
To support continuous learning, DIA brings you complimentary digital downloads to spur thought, reflection, collaboration, and action. In your Resource Kit, you'll find links to intriguing articles from the DIA Global Forum and our peer-reviewed journal, Therapeutic Innovation & Regulatory Science (TIRS), exclusive podcast interviews, session recordings from DIA events, and more!
FDA's Real World Evidence Program Moving Forward
Nurturing Growth of RWD into RWE in Japan
Finally Time for Real World Evidence in Canada?
Podcast: Statistical Strategies for Using Sources of Safety Data
Video: Advancing the Use of Real world Evidence for Regulatory Decision-Making